As SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) continues to inflict chaos globally, a new variant officially known as B.1.1.
View Article and Find Full Text PDFObjective: We aimed to assess the incidence, management, and visual outcome of acute endophthalmitis in patients following intravitreal bevacizumab injection in a tertiary care setup. It was a prospective and single-center database study.
Patients And Methods: Patients receiving intravitreal bevacizumab injections for various retinal vascular diseases from January 2019 to September 2020.